Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

This strategy has already resulted in the Sanofi partnership we announced this year, which has enabled us to transition away ...

The company now expects $650 million to $700 million in revenue for the year, down from previous guidance of $700 million to ...

In a report released today, Brendan Smith from TD Cowen maintained a Hold rating on Novavax (NVAX – Research Report), with a price target ...

Novavax Inc (NVAX) reports increased product sales and a strong cash position, while revising revenue guidance and navigating ...

Yes, you can get your flu and COVID-19 shots at the same time. Don't call them boosters — they're not just another dose of ...

The US Food and Drug Administration (FDA) has removed the clinical hold on the Investigational New Drug (IND) application for ...

In its recent third-quarter 2024 earnings report, Novavax highlighted significant advancements in its vaccine portfolio, including the removal of a clinical hold by the U.S. FDA on its ...

The coronavirus and influenza are escape artists that constantly ... The Pfizer and Moderna shots are formulated against a ...

Wall Street's main indexes were little changed on Tuesday following post-election gains over the past few days.